pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,251 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1075Endpoints809BioPharma Dive312BioSpace246Fierce Biotech230onclive165raps87globenewswire health
therapy area
allOncology6443Rare Disease1527Cardiology1222Immunology1118Hematology1099Vaccines976Pulmonology
  • Rural U.S. faces growing maternity care deserts despite falling fertility rates
    Pregnant women in many rural parts of the United States often must travel two hours or more to reach a hospital that can deliver a baby, putting them at risk if labor starts early or complications…
    STAT · 2mo agoNegative↗ source
  • Federal grant delays threaten disability research and services
    Grants from the National Institute on Disability, Independent Living, and Rehabilitation Research have been postponed by several months, leaving researchers uncertain about funding. The delays are…
    STAT · 2mo agoRegulatoryNegative↗ source
← prev
page 55 of 91
next →
73
fda recalls56
fda medwatch48
fda press30
945
Psychiatry & CNS761
Ophthalmology455
Pain428
Endocrinology & Metabolism403
Infectious Disease381
  • Protego Biopharma appoints Jae Kim as chief medical officer
    Protego Biopharma announced the addition of Jae Kim to its executive team as chief medical officer. Kim comes to Protego after serving as chief medical officer at both Septerna and Design Therapeu…
    STAT · 2mo agoNeutral↗ source
  • Ebola outbreak in Congo and Uganda surges 38% in a week, death toll exceeds 200
    The Africa CDC reported that the Ebola outbreak affecting eastern Congo and Uganda has now resulted in more than 200 deaths within its first month. Confirmed cases have risen to 894 across 32 heal…
    STAT · 2mo agoNegative↗ source
  • Novo Nordisk invests $380M to expand manufacturing in Czech Republic and China, while Cellares raises $50M Series D
    Novo Nordisk announced a significant investment to broaden its manufacturing footprint in both China and the Czech Republic. In the Czech Republic, the company is allocating roughly $380 million t…
    Endpoints · 2mo agoDealPositive↗ source
  • CMS recalculates 2026 Medicare Advantage star ratings, increasing program volatility and affecting $16 billion in bonuses
    Federal officials have issued a new memo that recalculates the quality ratings for 2026 Medicare Advantage plans. The change follows another lawsuit from insurers that contest lower star ratings,…
    STAT · 2mo agoRegulatoryNegative↗ source
  • FDA advisory panel backs Moderna seasonal mRNA flu vaccine after earlier controversy
    A Food and Drug Administration advisory committee unanimously endorsed Moderna’s seasonal mRNA flu vaccine on Thursday, after the product became the focus of controversy earlier this year when a se…
    STAT · 2mo agoRegulatoryPositive↗ source
  • Eli Lilly stops 340B discounts for hospitals that did not submit required claims data
    Eli Lilly has begun withdrawing the federally mandated 340B price discounts from a handful of hospitals that have failed to provide the comprehensive claims data the company requires. The move fol…
    STAT · 2mo agoRegulatoryNegative↗ source
  • FDA lifts opposition to Huntington’s disease gene therapy, clearing path for development
    The Readout Loud podcast this week highlighted a regulatory shift for a gene therapy aimed at Huntington’s disease. The Food and Drug Administration reversed its earlier opposition, removing a key…
    STAT · 2mo agoRegulatoryPositive↗ source
  • FDA advisory panel unanimously backs Moderna’s flu vaccine
    The FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend Moderna’s seasonal influenza vaccine. The vote overturns earlier hesitations from previous agen…
    Endpoints · 2mo agoRegulatoryPositive↗ source
  • U.S. Treasury Considers New Screening Rules for Investments in Chinese Biotech
    Treasury Department officials are reviewing possible measures to screen U.S. capital flowing into Chinese biotechnology firms, according to multiple sources familiar with the discussions. The revi…
    Endpoints · 2mo agoRegulatoryNegative↗ source
  • Eli Lilly stops 340B discounts for dozens of hospitals that did not submit claims data
    Eli Lilly has begun removing the federally mandated 340B price discounts for a few dozen hospitals that have not provided the required claims data. The company said the step follows a warning it is…
    STAT · 2mo agoRegulatoryNegative↗ source
  • STAT Health Tech examines whether wearables benefit cardiovascular patients
    Mario Aguilar writes in a STAT Health Tech newsletter that the issue of wearables for people with cardiovascular disease is under review. The piece notes that researchers have been studying whether…
    STAT · 2mo agoNeutral↗ source
  • Cambrian’s experimental longevity drug shown to mimic exercise effects
    Cambrian Therapeutics reported early data on a new compound aimed at extending healthy lifespan by reproducing some benefits of physical activity. The preclinical studies described in the newslett…
    STAT · 2mo agoNeutral↗ source
  • IRA's Medicare out-of-pocket cap increased access to drugs, study finds
    Medication usage, particularly for the most expensive drugs, increased significantly shortly after the Medicare annual out-of-pocket cost cap took effect in January 2025, a study published in JAMA…
    Endpoints · 2mo ago↗ source
  • Prepping for peptides
    It wasn’t too many years ago when we were busy theorizing about the market opportunity for GLP-1 weight loss drugs. Now, the big question is the moneymaking potential for other peptides that might…
    Endpoints · 2mo ago↗ source
  • Pfizer CFO to depart; GSK wins approval for UTI drug
    Plus news about Apellis Pharmaceuticals, Servier, TORL BioTherapeutics, Verastem, Corcept Therapeutics, Legend Biotech, COUR Pharmaceuticals, cAMPfield Therapeutics and LabGenius Therapeutics. 👋 P…
    Endpoints · 2mo ago↗ source
  • STAT+: Shingles vaccine may lower dementia risk, new study finds
    Nursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a new study found.
    STAT · 2mo ago↗ source
  • RA, Forbion and Sanofi Ventures appear to back new eye drug from Korea
    The trend continues in which big-name venture investors band together to back new companies with an experimental medicine developed by another biotech. RA Capital and Forbion — partners on a couple…
    Endpoints · 2mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
    Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer
    STAT · 2mo ago↗ source
  • Novocure’s electric fields therapy fails key glioblastoma study
    Novocure reported Thursday morning that its electric fields device combined with chemoradiation failed to extend glioblastoma patients' lives in a Phase 3 study, dampening the company's hopes of ex…
    Endpoints · 2mo ago↗ source
  • How many Americans can afford high-quality health care? A new poll finds the number has fallen
    A new poll shows only about half of U.S. adults could afford their health care and had access to quality care last year.
    STAT · 2mo ago↗ source
  • Innoviva revives Lyndra's long-acting oral drug platform
    A healthcare asset and royalties holding company is bringing a long-acting oral medicine approach back to life, resurrecting a drug delivery platform that had accumulated more than $380 million in…
    Endpoints · 2mo ago↗ source
  • Six of the biggest health news stories today
    High-end infant formula scrutiny, the spread of synthetic opioids, and more health news from Morning Rounds
    STAT · 2mo ago↗ source
  • Moderna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs
    → In preparation for potential new product launches, Moderna has selected Ester Banque as chief commercial officer and expanded the role of president Stephen Hoge. Banque was head of US operations…
    Endpoints · 2mo ago↗ source